Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Rheumatol. 2000 Nov;12(6):492-7.

Current approach to the treatment of polymyositis and dermatomyositis.

Author information

  • 1University of Pittsburgh, Pennsylvania 15261, USA. oddis@msx.dept-med.pitt.edu

Abstract

Although corticosteroids remain the mainstay of treatment for the inflammatory myopathies, their use is complicated by many side effects. Other immunosuppressive agents, alone or in combination, are being increasingly used for patients with other severe disease or treatment-related complications. Pulmonary disease remains a serious source of morbidity and mortality in myositis patients. Cyclophosphamide, cyclosporine, and tacrolimus are efficacious in patients with interstitial lung disease. Intravenous immunoglobulin is not only effective for the cutaneous complications of dermatomyositis but has been helpful in other extramuscular manifestations.

PMID:
11092197
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk